Page last updated: 2024-08-22

clodronic acid and Osteoporosis

clodronic acid has been researched along with Osteoporosis in 76 studies

Research

Studies (76)

Timeframe	Studies, this research(%)	All Research%
pre-1990	5 (6.58)	18.7374
1990's	24 (31.58)	18.2507
2000's	28 (36.84)	29.6817
2010's	18 (23.68)	24.3611
2020's	1 (1.32)	2.80

Authors

Authors	Studies
Bhardwaj, A; Sinha, NK; Swe, KMM	1
Allegra, A; Cervino, G; Cicciù, M; De Ponte, FS; Lauritano, F; Musolino, C; Nastro Siniscalchi, E; Oteri, G	1
Bianchi, G; Cantarini, L; Dalle Carbonare, L; Frediani, B; Giusti, A; Malavolta, N; Molfetta, L; Saviola, G	1
Scheer, V	1
Bertoldi, I; Cantarini, L; Filippou, G; Frediani, B; Galeazzi, M; Nicosia, A; Picerno, V; Pierguidi, S	1
Angioni, A; Bartuli, A; Buonuomo, PS; Digilio, MC; Gnazzo, M; Grandin, A; Lepri, FR; Macchiaiolo, M; Mennini, M	1
Baraldi, E; Cremonesi, G; Frediani, B	1
Aapro, M; Albert, US; Bergh, J; Body, JJ; Cameron, D; Clézardin, P; Coleman, RE; Conte, PF; Cortes, J; Costa, L; Di Leo, A; Diel, I; Dodwell, D; Ejlertsen, B; Gnant, M; Gray, R; Hadji, P; Harbeck, N; Holen, I; Kaufmann, M; Markopoulos, C; Martin, M; Powles, TJ; Santini, D; Smith, I; Thurlimann, B; Untch, M; Wilson, C	1
Bhardwaj, A; Osunkwo, I; Sinha, NK; Swe, KM	1
Mészaros, Á; Veszelyné Kotán, E	2
Blomqvist, C; Elomaa, I; Saarto, T; Vehmanen, L	1
Bartl, R	1
Cavalieri, L; Cremonesi, G; Frediani, B	1
Mosekilde, L; Pinholt, EM; Rejnmark, L; Schwartz, K; Vestergaard, P	1
Deuber, HJ; Theiss, F	1
Bennett, DL; Post, RD	1
Ludwig, H; Zojer, N	1
Carrassi, A; Lodi, G; Sardella, A; Tarozzi, M	1
Calcagnile, F; Grimaldi, A; Muratore, M; Quarta, E; Quarta, L	1
Aro, HT; Heervä, E; Peltonen, J; Peltonen, S; Svedström, E; Väänänen, K	1
Morgans, AK; Smith, MR	1
Haderslev, KV; Sorensen, HA; Staun, M; Tjellesen, L	1
Crisafulli, A; Di Pietro, C; Frisina, N; Gaudio, A; Lasco, A; Meo, A; Morabito, N	1
Brandi, ML; Ghinoi, V	1
Fu, Y; Li, H; Zheng, C	1
Coleman, RE	1
Saad, F	1
Bankhead, C	1
Acciai, C; Baldi, F; Falsetti, P; Filippou, G; Frediani, B; Marcolongo, R	1
Fiore, CE; Pennisi, P; Pizzarelli, G; Riccobene, S; Spina, M	1
Adams, J; Aropuu, S; Beneton, M; Davies, M; Francis, RM; Jalava, T; Kanis, JA; Kayan, K; Kenraali, J; McCloskey, E; Pylkkänen, L; Robinson, J; Selby, P	1
Hershman, D; Narayanan, R	1
Melchior, R; Schumacher, R; Spranger, J; Zabel, B	1
Reszka, AA; Rodan, GA	1
Hasegawa, M; Hayashi, K; Kurata, Y; Mizutani, M; Nisikawa, M; Nomura, S; Saigo, K; Suehiro, A; Takubo, T; Tamaki, S; Uemura, Y	1
Aropuu, S; Ashford, R; Beneton, M; Brazier, J; Charlesworth, D; Cliffe, J; deTakats, D; Dey, A; Forster, M; Jalava, T; Kanis, JA; Kayan, K; Kersh, L; McCloskey, EV; Nichol, J; Orgee, J	1
Afonso, Y; Bruna, P; Hering, FO; Meller, A; Rodrigues, P	1
Abitbol, V; Allez, M; Bouhnik, Y; Briot, K; Charachon, A; Chaussade, S; Coffin, B; Lamarque, D; Roux, C; Roy, C; Seksik, P	1
Beneton, M; Bonnet, N; Charlesworth, D; Eastaugh, J; Kanis, JA; McCloskey, EV; Parry, A; Threlkeld, J; Vasireddy, S	1
Chesnut, CH	1
Bonjour, JP; Fleisch, H; Hefti, E; Schenk, R; Trechsel, U	1
Goa, KL; Plosker, GL	1
Alfano, FS; Basini, G; Campanini, C; Fantuzzi, M; Gatti, C; Girasole, G; Passeri, M; Pedrazzoni, M	1
Bauer, R; Jaspers, C; König, E; Lederbogen, S; Reinwein, D	1
Fleisch, H	2
Clemens, MR; Fessele, K; Heim, ME	1
Aaron, J; Beneton, MN; Eyres, K; Fern, D; Kanis, JA; Khan, S; McCloskey, EV; Sirtori, P	1
Beltrametti, P; Binelli, L; Gallazzi, M; Sinigaglia, L; Varenna, M	1
Beyeler, C; Dahinden, C; Gerber, NJ; Hunziker, T; Lämmle, B; Lehmann, T; Olah, AJ; Vock, P	1
Ashley, S; Hanson, J; Kanis, JA; McCloskey, E; Paterson, AH; Powles, TJ	1
Licata, AA	1
Fleisch, HA	1
Kaastad, TS; Madsen, JE; Narum, S; Nordsletten, L; Obrant, KJ; Reikerâs, O; Stromme, JH	1
Herrala, J; Impivaara, O; Liippo, K; Nieminen, MM; Puolijoki, H; Raitio, M; Tala, E	1
Blomqvist, C; Elomaa, I; Risteli, J; Risteli, L; Saarto, T; Sarna, S	1
Grotz, W; Niessen, A; Rump, JA; Schmidt-Gayk, H; Schollmeyer, P	1
Kalliovalkama, J; Kankaanranta, H; Lähteenmäki, T; Pörsti, I; Salenius, JP; Sisto, T; Wu, X; Ylitalo, P; Ylitalo, R	1
Grotz, WH; Kirste, G; Niessen, A; Olschewski, M; Reichelt, A; Rump, LC; Schmidt-Gayk, H; Schollmeyer, PJ	1
Gennari, C; Reginster, JY	1
Ashley, S; Kanis, JA; McCloskey, EV; Paterson, AH; Powles, T; Spector, T	1
Cocchi, D; Paganelli, C; Zaffe, D	1
Fallon, JJ; Goldstein, MF; Harning, R	1
Casciari, C; Cristallini, S; Filipponi, P; Garinei, P; Policani, G; Schifini, MF	1
Balestra, V; Monteforte, P; Rovetta, G	1
Cundy, T; Zacharin, M	1
Bain, S; Barnes, J; Golub, LM; Liang, CT; Liu, Y; Llavaneras, A; Puerner, D; Ramamurthy, N; Strachan, MJ	1
Adams, J; Beneton, M; Bernard, J; Davies, M; de Takats, D; Francis, R; Jalava, T; Kanis, JA; Löyttyniemi, E; McCloskey, E; Pande, K; Robinson, J; Selby, P	1
Calcagnile, F; Cosentino, L; Muratore, L; Muratore, M; Quarta, E; Santacesaria, G	1
Maggiani, G; Molfetta, L; Monteforte, P; Rovetta, G	1
Durnova, G; Ilyina-Kakueva, E; Morukov, B	1
Huntoon, CL; LeBlanc, A; Schneider, VS	1
Henning, HV; Warneke, G	1
Onge, MS; Parker, B; Wink, CS	1
Wink, CS	1

Reviews

23 review(s) available for clodronic acid and Osteoporosis

Article	Year
Treatment for osteoporosis in people with beta-thalassaemia. The Cochrane database of systematic reviews, 2023, 05-09, Volume: 5 Topics: Adult; Alendronate; beta-Thalassemia; Child; Clodronic Acid; Denosumab; Diphosphonates; Female; Fractures, Bone; Humans; Male; Middle Aged; Osteoporosis; Pamidronate	2023
Clodronate in the management of different musculoskeletal conditions. Minerva medica, 2018, Volume: 109, Issue:4 Topics: Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Humans; Muscle Neoplasms; Musculoskeletal Diseases; Orthopedic Procedures; Osteoarthritis; Osteoporosis	2018
Effect of clodronate treatment on risk of fracture: a systematic review and meta-analysis. Calcified tissue international, 2014, Volume: 95, Issue:4 Topics: Bone Density Conservation Agents; Clodronic Acid; Female; Fracture Healing; Fractures, Bone; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal; Probability; Prospective Studies; Randomized Controlled Trials as Topic	2014
Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel. Annals of oncology : official journal of the European Society for Medical Oncology, 2016, Volume: 27, Issue:3 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Consensus; Diphosphonates; Europe; Female; Humans; Imidazoles; Neoplasm Recurrence, Local; Osteoporosis; Surveys and Questionnaires; Zoledronic Acid	2016
Treatment for osteoporosis in people with ß-thalassaemia. The Cochrane database of systematic reviews, 2016, Mar-10, Volume: 3 Topics: Adolescent; Adult; Alendronate; beta-Thalassemia; Bone Density; Bone Density Conservation Agents; Child; Clodronic Acid; Diphosphonates; Female; Femur Neck; Humans; Male; Middle Aged; Osteoporosis; Randomized Controlled Trials as Topic; Zinc Sulfate	2016
[Therapeutic practice of bisphosphonate use and related pharmaceutical issues I]. Acta pharmaceutica Hungarica, 2016, Volume: 86, Issue:1 Topics: Alendronate; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Bone; Humans; Hungary; Ibandronic Acid; Imidazoles; Osteoporosis; Pamidronate; Risedronic Acid; Zoledronic Acid	2016
Clodronic acid formulations available in Europe and their use in osteoporosis: a review. Clinical drug investigation, 2009, Volume: 29, Issue:6 Topics: Bone Density Conservation Agents; Clodronic Acid; Drug Administration Routes; Europe; Humans; Osteoporosis	2009
[Bisphosphonates in adjuvant therapy of breast cancer]. Medizinische Klinik (Munich, Germany : 1983), 2010, Volume: 105, Issue:9 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Controlled Clinical Trials as Topic; Diphosphonates; Drug Approval; Estrogen Antagonists; Evidence-Based Medicine; Female; Humans; Imidazoles; Neoplasm Staging; Osteoporosis; Pamidronate; Survival Rate; Zoledronic Acid	2010
Supportive therapy in multiple myeloma. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2011, Volume: 183 Topics: Anemia; Blood Transfusion; Bone Diseases; Calcitonin; Clodronic Acid; Diphosphonates; Erythropoietin; Fractures, Bone; Hematinics; Humans; Hypercalcemia; Imidazoles; Multiple Myeloma; Osteoporosis; Pamidronate; Recombinant Proteins; Renal Insufficiency; Zoledronic Acid	2011
Clinical utility of clodronate in the prevention and management of osteoporosis in patients intolerant of oral bisphosphonates. Drug design, development and therapy, 2011, Volume: 5 Topics: Clodronic Acid; Diphosphonates; Female; Humans; Male; Osteoporosis; Osteoporosis, Postmenopausal	2011
Bone-targeted agents: preventing skeletal complications in prostate cancer. The Urologic clinics of North America, 2012, Volume: 39, Issue:4 Topics: Androgen Antagonists; Antibodies, Monoclonal, Humanized; Bone Density; Bone Neoplasms; Clinical Trials as Topic; Clodronic Acid; Denosumab; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Osteoclasts; Osteoporosis; Pamidronate; Prostatic Neoplasms; Quality of Life; Samarium; Toremifene; Zoledronic Acid	2012
Clodronate: mechanisms of action on bone remodelling and clinical use in osteometabolic disorders. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:11 Topics: Antimetabolites; Bone and Bones; Bone Diseases; Bone Remodeling; Clinical Trials as Topic; Clodronic Acid; Drug Evaluation, Preclinical; Humans; Hyperkalemia; Hyperparathyroidism; Neoplasms; Osteitis Deformans; Osteoporosis	2002
Current and future status of adjuvant therapy for breast cancer. Cancer, 2003, Feb-01, Volume: 97, Issue:3 Suppl Topics: Anastrozole; Antineoplastic Agents, Hormonal; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Female; Forecasting; Humans; Nitriles; Osteoporosis; Receptors, Estrogen; Tamoxifen; Triazoles	2003
Prevention and management of osteoporosis in women with breast cancer and men with prostate cancer. Current oncology reports, 2004, Volume: 6, Issue:4 Topics: Absorptiometry, Photon; Alendronate; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Breast Neoplasms; Calcitonin; Calcium; Clodronic Acid; Diphosphonates; Drug Therapy, Combination; Estrogens; Etidronic Acid; Female; Humans; Imidazoles; Male; Osteoporosis; Prostatic Neoplasms; Quality of Life; Risedronic Acid; Risk Factors; Treatment Outcome; Vitamin D; Zoledronic Acid	2004
Mechanism of action of bisphosphonates. Current osteoporosis reports, 2003, Volume: 1, Issue:2 Topics: Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Osteoporosis; Sensitivity and Specificity; Structure-Activity Relationship	2003
Clodronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs, 1994, Volume: 47, Issue:6 Topics: Animals; Bone Neoplasms; Bone Resorption; Calcinosis; Clinical Trials as Topic; Clodronic Acid; Dose-Response Relationship, Drug; Half-Life; Humans; Hydroxyproline; Hypercalcemia; Infusions, Intravenous; Metabolic Clearance Rate; Neoplasms; Osteitis Deformans; Osteoporosis; Tissue Distribution	1994
Rationale for the use of clodronate in osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 1993, Volume: 3 Suppl 2 Topics: Bone Remodeling; Bone Resorption; Clodronic Acid; Diphosphonates; Humans; Osteoporosis; Spinal Fractures	1993
Bisphosphonate therapy. The American journal of the medical sciences, 1997, Volume: 313, Issue:1 Topics: Alendronate; Animals; Bone Density; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Osteoclasts; Osteoporosis; Osteoporosis, Postmenopausal; Pamidronate; Risedronic Acid	1997
Bisphosphonates: preclinical aspects and use in osteoporosis. Annals of medicine, 1997, Volume: 29, Issue:1 Topics: Alendronate; Animals; Bone Resorption; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Osteoporosis; Pamidronate	1997
Bisphosphonates and osteoporosis treatment in Italy. Aging (Milan, Italy), 1998, Volume: 10, Issue:4 Topics: Aged; Alendronate; Bone and Bones; Bone Density; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Italy; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Safety	1998
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest, 1999, Volume: 116, Issue:6 Topics: Administration, Inhalation; Administration, Oral; Adult; Alendronate; Asthma; Bone Density; Bone Remodeling; Calcitonin; Clodronic Acid; Etidronic Acid; Fluorides; Glucocorticoids; Hormone Replacement Therapy; Humans; Lung Diseases, Obstructive; Osteoporosis; Prednisone; Time Factors	1999
[Bisphosphonates. Drugs for the treatment of disorders of calcium and bone metabolism]. Der Internist, 1992, Volume: 33, Issue:6 Topics: Bone Neoplasms; Calcium; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Osteoporosis; Structure-Activity Relationship	1992
[Biphosphonate as a therapeutic drug--experimental studies and clinical application]. Therapeutische Umschau. Revue therapeutique, 1985, Volume: 42, Issue:6 Topics: Animals; Calcinosis; Clodronic Acid; Diphosphonates; Etidronic Acid; Humans; Hypercalcemia; Hyperparathyroidism; Myositis Ossificans; Osteitis Deformans; Osteolysis; Osteoporosis; Pamidronate; Urinary Calculi	1985

Trials

19 trial(s) available for clodronic acid and Osteoporosis

Article	Year
Improved efficacy of intramuscular weekly administration of clodronate 200 mg (100 mg twice weekly) compared with 100 mg (once weekly) for increasing bone mineral density in postmenopausal osteoporosis. Clinical drug investigation, 2013, Volume: 33, Issue:3 Topics: Aged; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Middle Aged; Osteoporosis; Postmenopause	2013
Ten-year follow-up of 3 years of oral adjuvant clodronate therapy shows significant prevention of osteoporosis in early-stage breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Sep-10, Volume: 26, Issue:26 Topics: Adult; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Breast Neoplasms; Clodronic Acid; Female; Follow-Up Studies; Humans; Middle Aged; Osteoporosis	2008
Effect of cyclical intravenous clodronate therapy on bone mineral density and markers of bone turnover in patients receiving home parenteral nutrition. The American journal of clinical nutrition, 2002, Volume: 76, Issue:2 Topics: Adult; Antimetabolites; Bone Density; Bone Resorption; Clodronic Acid; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Osteoporosis; Parathyroid Hormone; Parenteral Nutrition, Home; Postmenopause; Premenopause; Reference Values	2002
Bisphosphonates in the treatment of thalassemia-induced osteoporosis. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2002, Volume: 13, Issue:8 Topics: Absorptiometry, Photon; Adolescent; Adult; Alendronate; Analysis of Variance; beta-Thalassemia; Biomarkers; Bone Density; Bone Remodeling; Clodronic Acid; Diphosphonates; Female; Humans; Male; Osteoporosis; Placebo Effect	2002
Effects of 4-year treatment with once-weekly clodronate on prevention of corticosteroid-induced bone loss and fractures in patients with arthritis: evaluation with dual-energy X-ray absorptiometry and quantitative ultrasound. Bone, 2003, Volume: 33, Issue:4 Topics: Absorptiometry, Photon; Adolescent; Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Arthritis; Arthritis, Psoriatic; Arthritis, Rheumatoid; Bone Density; Calcium, Dietary; Clodronic Acid; Drug Administration Schedule; Female; Fractures, Bone; Humans; Middle Aged; Osteoporosis; Prednisone; Ultrasonography; Vitamin D	2003
Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoporosis. Journal of bone and mineral metabolism, 2003, Volume: 21, Issue:6 Topics: Adult; Amino Acids; beta-Thalassemia; Bone and Bones; Calcium; Clodronic Acid; Creatine; Humans; Injections, Intravenous; Male; Osteoporosis; Time Factors; Ultrasonography; Vitamin D	2003
Clodronate reduces vertebral fracture risk in women with postmenopausal or secondary osteoporosis: results of a double-blind, placebo-controlled 3-year study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2004, Volume: 19, Issue:5 Topics: Aged; Alkaline Phosphatase; Antimetabolites; Bone Density; Clodronic Acid; Collagen; Collagen Type I; Double-Blind Method; Female; Humans; Middle Aged; Osteoporosis; Osteoporosis, Postmenopausal; Peptides; Prospective Studies; Risk Factors; Spinal Fractures	2004
Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2007, Volume: 22, Issue:1 Topics: Aged; Aged, 80 and over; Body Mass Index; Body Size; Bone Density Conservation Agents; Clodronic Acid; England; Family Practice; Female; Humans; Osteoporosis; Placebos	2007
Comparative study of the protective effect of different intravenous bisphosphonates on the decrease in bone mineral density in patients submitted to radical prostatectomy undergoing androgen deprivation therapy. A prospective open-label controlled study. International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:4 Topics: Adenocarcinoma; Aged; Androgen Antagonists; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Diphosphonates; Gonadotropin-Releasing Hormone; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Orchiectomy; Osteoporosis; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Zoledronic Acid	2007
A double-blind placebo-controlled study of intravenous clodronate for prevention of steroid-induced bone loss in inflammatory bowel disease. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2007, Volume: 5, Issue:10 Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Femur Neck; Follow-Up Studies; Glucocorticoids; Humans; Inflammatory Bowel Diseases; Injections, Intravenous; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Retrospective Studies; Thoracic Vertebrae; Treatment Outcome	2007
Vertebral fracture assessment (VFA) with a densitometer predicts future fractures in elderly women unselected for osteoporosis. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2008, Volume: 23, Issue:10 Topics: Absorptiometry, Photon; Administration, Oral; Aged; Bone Density; Clodronic Acid; Cohort Studies; Double-Blind Method; Humans; Male; Osteoporosis; Placebos; Risk Factors; Spinal Fractures	2008
Multiple myeloma: effect of daily dichloromethylene bisphosphonate on skeletal complications. Annals of hematology, 1993, Volume: 66, Issue:3 Topics: Adult; Aged; Analgesia; Bone Diseases; Bone Resorption; Calcium; Clodronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Male; Melphalan; Middle Aged; Multiple Myeloma; Osteoporosis; Prednisolone; Prospective Studies	1993
Clodronate is effective in preventing corticosteroid-induced bone loss among asthmatic patients. Bone, 1998, Volume: 22, Issue:5 Topics: Absorptiometry, Photon; Administration, Inhalation; Administration, Oral; Analgesics, Non-Narcotic; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bone Density; Clodronic Acid; Dose-Response Relationship, Drug; Double-Blind Method; Female; Femur; Femur Neck; Glucocorticoids; Humans; Lumbar Vertebrae; Male; Osteoporosis; Prednisolone	1998
Aminoterminal propeptide of type I procollagen (PINP) correlates to bone loss and predicts the efficacy of antiresorptive therapy in pre- and post-menopausal non-metastatic breast cancer patients. British journal of cancer, 1998, Volume: 78, Issue:2 Topics: Bone Density; Bone Resorption; Breast Neoplasms; Chemotherapy, Adjuvant; Clodronic Acid; Female; Humans; Osteoporosis; Peptide Fragments; Procollagen	1998
Treatment of bone pain after kidney transplantation. Transplantation proceedings, 1998, Volume: 30, Issue:5 Topics: Absorptiometry, Photon; Biomarkers; Bone Density; Bone Diseases, Metabolic; Calcitonin; Calcium; Clodronic Acid; Female; Humans; Kidney Transplantation; Male; Middle Aged; Osteoporosis; Pain; Pain Measurement; Postoperative Complications	1998
Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation, 1998, Oct-27, Volume: 66, Issue:8 Topics: Administration, Intranasal; Administration, Oral; Adult; Bone Density; Bone Diseases, Metabolic; Calcitonin; Calcium; Clodronic Acid; Female; Humans; Kidney Transplantation; Male; Middle Aged; Osteoporosis; Pilot Projects; Postoperative Complications; Prospective Studies; Sex Characteristics	1998
A high incidence of vertebral fracture in women with breast cancer. British journal of cancer, 1999, Volume: 79, Issue:7-8 Topics: Administration, Oral; Age Factors; Aged; Analgesics, Non-Narcotic; Antineoplastic Agents, Hormonal; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Cohort Studies; Double-Blind Method; Female; Humans; Incidence; Middle Aged; Neoplasm Recurrence, Local; Odds Ratio; Osteoporosis; Spinal Fractures; Tamoxifen	1999
Effects of clodronate on vertebral fracture risk in osteoporosis: a 1-year interim analysis. Bone, 2001, Volume: 28, Issue:3 Topics: Bone Density; Clodronic Acid; Female; Humans; Incidence; Male; Osteoporosis; Risk Assessment; Spinal Fractures; United Kingdom	2001
Prevention with clodronate of osteoporosis secondary to inhaled corticosteroid treatment in patients with chronic asthmatic bronchitis. International journal of clinical pharmacology research, 2000, Volume: 20, Issue:3-4 Topics: Administration, Inhalation; Aged; Androstadienes; Anti-Asthmatic Agents; Asthma; Beclomethasone; Bone Density; Chronic Disease; Clodronic Acid; Fluticasone; Humans; Infusion Pumps; Male; Middle Aged; Osteoporosis	2000

Other Studies

34 other study(ies) available for clodronic acid and Osteoporosis

Article	Year
Spontaneous Healing of Clodronate-Related Osteonecrosis of the Jaw. The Journal of craniofacial surgery, 2017, Volume: 28, Issue:7 Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Clodronic Acid; Female; Humans; Osteoporosis; Wound Healing	2017
Transient osteoporosis: an unusual presentation of hip pain in a trail runner. BMJ case reports, 2019, Jul-10, Volume: 12, Issue:7 Topics: Acute Pain; Adult; Analgesia; Arthralgia; Bone Density Conservation Agents; Bone Marrow Diseases; Clodronic Acid; Edema; Electromagnetic Radiation; Hip Joint; Humans; Magnetic Resonance Imaging; Male; Osteoporosis; Radiography; Radionuclide Imaging; Running; Vitamin D	2019
Thricho-rhino-phalangeal syndrome and severe osteoporosis: a rare association or a feature? An effective therapeutic approach with biphosphonates. American journal of medical genetics. Part A, 2014, Volume: 164A, Issue:3 Topics: Bone and Bones; Bone Density; Bone Density Conservation Agents; Child; Clodronic Acid; DNA Mutational Analysis; DNA-Binding Proteins; Fingers; Hair Diseases; Humans; Langer-Giedion Syndrome; Male; Nose; Osteoporosis; Phenotype; Radiography; Repressor Proteins; Transcription Factors	2014
[Bisphosphonate use and related pharmaceutical issues II]. Acta pharmaceutica Hungarica, 2016, Volume: 86, Issue:1 Topics: Administration, Oral; Alendronate; Bone Density Conservation Agents; Bone Neoplasms; Clodronic Acid; Confounding Factors, Epidemiologic; Diphosphonates; Drug Costs; Drug Prescriptions; Drugs, Generic; Humans; Hungary; Ibandronic Acid; Imidazoles; National Health Programs; Osteoporosis; Pamidronate; Retrospective Studies; Risedronic Acid; Zoledronic Acid	2016
[Bisphosphonates for osseus invasion caused by bronchial carcinoma]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:48 Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Bronchial Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Injections, Intravenous; Osteoporosis; Zoledronic Acid	2008
Gastric and esophagus events before and during treatment of osteoporosis. Calcified tissue international, 2010, Volume: 86, Issue:2 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Case-Control Studies; Causality; Clodronic Acid; Cohort Studies; Denmark; Diphosphonates; Esophageal Perforation; Etidronic Acid; Female; Gastrointestinal Tract; Humans; Iatrogenic Disease; Male; Middle Aged; Osteoporosis; Peptic Ulcer; Raloxifene Hydrochloride; Risk Assessment; Risk Factors	2010
The role of the radiologist when encountering osteoporosis in women. AJR. American journal of roentgenology, 2011, Volume: 196, Issue:2 Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Calibration; Clodronic Acid; Female; Femoral Fractures; Humans; Magnetic Resonance Imaging; Mass Screening; Middle Aged; Osteoporosis; Reproducibility of Results; Spinal Fractures	2011
Bisphosphonate-related osteonecrosis of the jaws associated with photodynamic therapy. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:10 Topics: Aged; Bone Density Conservation Agents; Carcinoma, Verrucous; Clodronic Acid; Female; Humans; Leukoplakia, Oral; Mandibular Diseases; Mandibular Neoplasms; Mesoporphyrins; Neoplasm Recurrence, Local; Osteonecrosis; Osteoporosis; Photochemotherapy; Photosensitizing Agents	2011
Osteoclasts derived from patients with neurofibromatosis 1 (NF1) display insensitivity to bisphosphonates in vitro. Bone, 2012, Volume: 50, Issue:3 Topics: Adult; Aged; Alendronate; Biomarkers; Bone Density; Bone Resorption; Cells, Cultured; Clodronic Acid; Diphosphonates; Female; Humans; Imidazoles; Lumbar Vertebrae; Male; Middle Aged; Neurofibromatosis 1; Osteoclasts; Osteoporosis; Zoledronic Acid	2012
[The study on the anti-osteoporosis effect of clodronate in ovariectomized rats]. Hua xi yi ke da xue xue bao = Journal of West China University of Medical Sciences = Huaxi yike daxue xuebao, 2000, Volume: 31, Issue:2 Topics: Animals; Antimetabolites; Bone Density; Clodronic Acid; Female; Organ Size; Osteoporosis; Ovariectomy; Random Allocation; Rats; Rats, Wistar; Uterus	2000
Bisphosphonates in prostate cancer: where are we and where should we go? Journal of the National Cancer Institute, 2003, Sep-03, Volume: 95, Issue:17 Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Clodronic Acid; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Infusions, Intravenous; Male; Neoplasms, Hormone-Dependent; Osteoporosis; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Zoledronic Acid	2003
Clinical trials test bisphosphonates in hormone-sensitive prostate cancer. Journal of the National Cancer Institute, 2003, Sep-03, Volume: 95, Issue:17 Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Neoplasms; Clodronic Acid; Diphosphonates; Disease-Free Survival; Humans; Imidazoles; Male; Multicenter Studies as Topic; Neoplasm Staging; Neoplasms, Hormone-Dependent; Osteoporosis; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Time Factors; Treatment Outcome; Zoledronic Acid	2003
Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis. European journal of pediatrics, 2005, Volume: 164, Issue:1 Topics: Age Factors; Antimetabolites; Bone Density; Child; Clodronic Acid; Humans; Infusions, Parenteral; Male; Osteoporosis; Puberty; Recurrence	2005
[Effect of glucocorticoids on bone mineral density in patients with idiopathic thrombocytopenic purpura]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2005, Volume: 46, Issue:2 Topics: Adult; Aged; Bone Density; Bone Density Conservation Agents; Clodronic Acid; Dose-Response Relationship, Drug; Female; Glucocorticoids; Humans; Male; Middle Aged; Osteoporosis; Prednisolone; Purpura, Thrombocytopenic, Idiopathic; Retrospective Studies	2005
Treatment of postmenopausal osteoporosis: some current concepts. Scottish medical journal, 1981, Volume: 26, Issue:1 Topics: Aged; Calcitonin; Calcium Carbonate; Clodronic Acid; Ergocalciferols; Estrogens; Female; Humans; Menopause; Methandrostenolone; Middle Aged; Osteoporosis; Physical Exertion; Sodium Fluoride; Stanozolol	1981
Increase of whole-body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clinical science (London, England : 1979), 1982, Volume: 62, Issue:4 Topics: Animals; Body Composition; Bone and Bones; Calcitriol; Calcium; Clodronic Acid; Female; Organ Size; Osteoporosis; Parathyroid Hormone; Rats; Rats, Inbred Strains; Sodium Fluoride	1982
Acute effects of bisphosphonates on new and traditional markers of bone resorption. Calcified tissue international, 1995, Volume: 57, Issue:1 Topics: Acid Phosphatase; Aged; Aged, 80 and over; Alendronate; Amino Acids; Biomarkers; Bone and Bones; Bone Resorption; Clodronic Acid; Collagen; Collagen Type I; Diphosphonates; Female; Humans; Hydroxyproline; Injections, Intravenous; Male; Middle Aged; Osteitis Deformans; Osteoporosis; Peptides; Time Factors	1995
[An unusual course of severe osteoporosis]. Der Internist, 1994, Volume: 35, Issue:10 Topics: Biopsy; Bone Density; Clodronic Acid; Follow-Up Studies; Humans; Ilium; Male; Mast Cells; Mastocytosis; Middle Aged; Osteoporosis; Radiography	1994
[Pharmacology of clodronate and its mechanism of action on bone resorption]. Bulletin du cancer, 1993, Volume: 80, Issue:10 Suppl Topics: Bone Resorption; Clodronic Acid; Humans; Osteoblasts; Osteoclasts; Osteolysis; Osteoporosis	1993
Transient osteoporosis of the hip: a densitometric study. Clinical rheumatology, 1996, Volume: 15, Issue:2 Topics: Absorptiometry, Photon; Adult; Analgesics, Non-Narcotic; Bone Density; Clodronic Acid; Femur; Follow-Up Studies; Hip Joint; Humans; Infusions, Intravenous; Male; Middle Aged; Osteoporosis	1996
Severe osteoporosis due to systemic mast cell disease: successful treatment with interferon alpha-2B. British journal of rheumatology, 1996, Volume: 35, Issue:9 Topics: Adult; Clodronic Acid; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Male; Mastocytosis; Osteoporosis; Palliative Care; Recombinant Proteins; Spinal Diseases; Urticaria Pigmentosa	1996
Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer. The Canadian journal of oncology, 1995, Volume: 5 Suppl 1 Topics: Analgesics, Non-Narcotic; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Etidronic Acid; Female; Fractures, Bone; Humans; Hypercalcemia; Multiple Myeloma; Osteoporosis; Pain; Pamidronate	1995
Effects of clodronate on cortical and trabecular bone in ovariectomized rats on a low calcium diet. Calcified tissue international, 1997, Volume: 61, Issue:2 Topics: Animals; Calcium, Dietary; Clodronic Acid; Disease Models, Animal; Female; Femur; Osteoporosis; Ovariectomy; Rats; Rats, Wistar; Strontium Radioisotopes; Tibia	1997
Accumulation of bisphosphonates in human artery and their effects on human and rat arterial function in vitro. Pharmacology & toxicology, 1998, Volume: 83, Issue:3 Topics: Animals; Arteries; Calcium Channel Blockers; Clodronic Acid; Diphosphonates; Drug Synergism; Etidronic Acid; Humans; Hypercalcemia; In Vitro Techniques; Male; Nifedipine; Osteoporosis; Pamidronate; Rats; Rats, Wistar; Vasoconstriction	1998
Induction and pharmacological treatment of oral osteopenia in rats. Minerva stomatologica, 1999, Volume: 48, Issue:3 Topics: Animals; Bone Diseases, Metabolic; Clodronic Acid; Disease Models, Animal; Estradiol; Female; Fractures, Bone; Male; Mandibular Fractures; Maxillary Fractures; Osteoporosis; Placebos; Rats; Rats, Sprague-Dawley	1999
Intermittent versus continuous clodronate administration in postmenopausal women with low bone mass. Bone, 2000, Volume: 26, Issue:3 Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Clodronic Acid; Female; Humans; Middle Aged; Osteoporosis; Postmenopause	2000
Intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs under experimental and clinical research, 2000, Volume: 26, Issue:1 Topics: Acute Disease; Aged; Analgesics, Non-Narcotic; Clodronic Acid; Female; Humans; Male; Middle Aged; Osteoporosis; Pain; Spinal Fractures	2000
Osteoporosis pseudoglioma syndrome: treatment of spinal osteoporosis with intravenous bisphosphonates. The Journal of pediatrics, 2000, Volume: 137, Issue:3 Topics: Analgesics, Non-Narcotic; Bone Density; Child; Clodronic Acid; Diphosphonates; Female; Fractures, Bone; Growth; Humans; Infusions, Intravenous; Male; Osteoporosis; Pain; Pamidronate; Spine; Syndrome; Vision Disorders	2000
A combination of subtherapeutic doses of chemically modified doxycycline (CMT-8) and a bisphosphonate (clodronate) inhibits bone loss in the ovariectomized rat: a dynamic histomorphometric and gene expression study. Current medicinal chemistry, 2001, Volume: 8, Issue:3 Topics: Animals; Bone and Bones; Bone Density; Clodronic Acid; Collagen; Collagenases; Disease Models, Animal; Doxycycline; Drug Therapy, Combination; Female; Femur; Gene Expression Regulation; Osteopontin; Osteoporosis; Ovariectomy; Protease Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sialoglycoproteins; Tetracyclines; Transcription, Genetic	2001
One-month follow-up of patients treated by intravenous clodronate for acute pain induced by osteoporotic vertebral fracture. Drugs under experimental and clinical research, 2001, Volume: 27, Issue:2 Topics: Acute Disease; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Clodronic Acid; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Osteoporosis; Pain; Spinal Fractures	2001
The effect of Lodronat(R) on development of osteoporosis in tail-suspended rats. Journal of gravitational physiology : a journal of the International Society for Gravitational Physiology, 1997, Volume: 4, Issue:2 Topics: Animals; Bone Development; Bone Resorption; Clodronic Acid; Hindlimb Suspension; Male; Osteoporosis; Rats; Rats, Wistar; Tibia; Weightlessness Simulation	1997
Prevention of space flight induced soft tissue calcification and disuse osteoporosis. Acta astronautica, 1993, Volume: 29, Issue:2 Topics: Bed Rest; Bone and Bones; Bone Demineralization, Pathologic; Calcinosis; Calcium; Clodronic Acid; Etidronic Acid; Fluorides; Gravity Suits; Humans; Kidney Calculi; Osteoporosis; Phosphates; Weightlessness Countermeasures; Weightlessness Simulation	1993
The effects of dichloromethylene biphosphonate on osteoporotic femora of adult castrate male rats. Acta anatomica, 1985, Volume: 124, Issue:1-2 Topics: Animals; Clodronic Acid; Diphosphonates; Disease Models, Animal; Male; Orchiectomy; Osteolysis; Osteoporosis; Rats	1985
A scanning electron-microscopic study of femoral bone surfaces from castrate rats treated with dichloromethylene biphosphonate. Acta anatomica, 1986, Volume: 126, Issue:1 Topics: Animals; Clodronic Acid; Diphosphonates; Femur; Male; Microscopy, Electron, Scanning; Orchiectomy; Osteoporosis; Periosteum; Rats; Rats, Inbred Strains	1986